AR202617A1 - Procedimiento para la preparacion de metitioetilclanoguanidinas heterociclicas - Google Patents

Procedimiento para la preparacion de metitioetilclanoguanidinas heterociclicas

Info

Publication number
AR202617A1
AR202617A1 AR258761A AR25876175A AR202617A1 AR 202617 A1 AR202617 A1 AR 202617A1 AR 258761 A AR258761 A AR 258761A AR 25876175 A AR25876175 A AR 25876175A AR 202617 A1 AR202617 A1 AR 202617A1
Authority
AR
Argentina
Prior art keywords
methioethylclanguanidins
heterocyclic
procedure
preparation
heterocyclic methioethylclanguanidins
Prior art date
Application number
AR258761A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of AR202617A1 publication Critical patent/AR202617A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
AR258761A 1973-07-13 1975-05-13 Procedimiento para la preparacion de metitioetilclanoguanidinas heterociclicas AR202617A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3342873A GB1431589A (en) 1973-07-13 1973-07-13 Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups

Publications (1)

Publication Number Publication Date
AR202617A1 true AR202617A1 (es) 1975-06-24

Family

ID=10352834

Family Applications (3)

Application Number Title Priority Date Filing Date
AR254698A AR204928A1 (es) 1973-07-13 1974-01-01 Procedimiento para la preparacion de(alquil-tioalquil)tioureas heterociclicas
AR258761A AR202617A1 (es) 1973-07-13 1975-05-13 Procedimiento para la preparacion de metitioetilclanoguanidinas heterociclicas
AR258762A AR202618A1 (es) 1973-07-13 1975-05-13 Procedimiento para la preparacion de metiltioalquilguanidinas heterociclicas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR254698A AR204928A1 (es) 1973-07-13 1974-01-01 Procedimiento para la preparacion de(alquil-tioalquil)tioureas heterociclicas

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR258762A AR202618A1 (es) 1973-07-13 1975-05-13 Procedimiento para la preparacion de metiltioalquilguanidinas heterociclicas

Country Status (31)

Country Link
US (1) US4499101A (es)
JP (1) JPS5830314B2 (es)
AR (3) AR204928A1 (es)
AT (1) AT346855B (es)
BE (1) BE816850A (es)
BG (1) BG25792A3 (es)
CA (1) CA1049524A (es)
CH (1) CH601252A5 (es)
CS (1) CS199255B2 (es)
DD (1) DD112449A5 (es)
DE (1) DE2433625A1 (es)
DK (1) DK334674A (es)
EG (1) EG11259A (es)
ES (3) ES428246A1 (es)
FI (1) FI213274A (es)
FR (1) FR2274298A1 (es)
GB (1) GB1431589A (es)
HU (1) HU169394B (es)
IE (1) IE39607B1 (es)
IL (1) IL45006A (es)
IN (1) IN140943B (es)
LU (1) LU70507A1 (es)
MW (1) MW2674A1 (es)
NL (1) NL7408942A (es)
NO (1) NO143063C (es)
OA (1) OA04814A (es)
PH (1) PH11618A (es)
PL (3) PL98609B1 (es)
SE (1) SE416202B (es)
SU (3) SU559647A3 (es)
ZM (1) ZM10374A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215125A (en) 1973-07-13 1980-07-29 Smith Kline & French Laboratories Limited Pyridyl ureas, thioureas and guanidines
US4070472A (en) * 1974-02-07 1978-01-24 Smith Kline & French Laboratories Limited Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
US4151289A (en) 1975-01-22 1979-04-24 Smith Kline & French Laboratories Limited Nitromethylene amidino derivatives containing imidazole groups
GB1542840A (en) * 1975-02-03 1979-03-28 Smith Kline French Lab Heterocyclic dithiocarbamates and isothioureas
US4120966A (en) 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic-methylthioethyl-dithiocarbamates and isothioureas
IL49528A (en) 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
IE47044B1 (en) 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
JPS5610175A (en) * 1979-07-06 1981-02-02 Fujisawa Pharmaceut Co Ltd Preparation of imidazole derivative
JPS5775975A (en) * 1980-08-27 1982-05-12 Glaxo Group Ltd Heterocyclic derivative, manufacture and medicinal composition containing same
DE3366369D1 (en) * 1982-03-17 1986-10-30 Smith Kline French Lab Pyridine derivatives
EP0199845B1 (de) * 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH & CO Imidazolylalkylguanidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3512084A1 (de) * 1985-04-02 1986-10-09 Ludwig Heumann & Co GmbH, 8500 Nürnberg Guanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
ES2108107T3 (es) * 1991-02-27 1997-12-16 Seed Capital Investments Derivados de imidazol que tienen actividad antagonista en el receptor h3 de histamina.
DK1032556T3 (da) * 1997-10-21 2008-03-25 Wyeth Corp Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
US7041702B1 (en) 1997-10-21 2006-05-09 Scion Pharmaceuticals, Inc. Pharmaceutically active compounds and methods of use
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292485A (es) * 1962-05-09
CH484918A (de) * 1965-10-28 1970-01-31 Ciba Geigy Verfahren zur Herstellung heterocyclischer, Aethylendoppelbindungen enthaltender Verbindungen
US3770755A (en) * 1967-09-26 1973-11-06 Ici Ltd 4-(4-bromophenyl)-2-(2-hydroxysopropyl) thiazole
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3868457A (en) * 1969-10-29 1975-02-25 Smith Kline French Lab Method of inhibiting histamine activity with guanidine compounds
US3749728A (en) * 1972-02-15 1973-07-31 Smith Kline French Lab N-cycloalkyl and n-cycloalkane-alkylthioamides
US3821229A (en) * 1972-12-07 1974-06-28 American Cyanamid Co Diquaternary salts of di-4-pyridyl ketone
US4013659A (en) * 1973-07-13 1977-03-22 Smith Kline & French Laboratories Limited Certain n,n'-disubstituted guanidine compounds and their use
US4154838A (en) * 1975-07-31 1979-05-15 Smith Kline & French Laboratories Limited Alkoxy pyridine

Also Published As

Publication number Publication date
BE816850A (fr) 1974-12-27
ZM10374A1 (en) 1975-04-21
HU169394B (es) 1976-11-28
IN140943B (es) 1977-01-01
AT346855B (de) 1978-11-27
AU6984574A (en) 1975-12-11
JPS5830314B2 (ja) 1983-06-28
CH601252A5 (es) 1978-06-30
SU567405A3 (ru) 1977-07-30
IE39607B1 (en) 1978-11-22
CS199255B2 (en) 1980-07-31
ES437770A1 (es) 1977-01-16
NO742563L (es) 1975-02-10
FR2274298A1 (fr) 1976-01-09
OA04814A (fr) 1980-10-31
JPS5032174A (es) 1975-03-28
IL45006A (en) 1978-07-31
SE7409188L (sv) 1975-01-14
IE39607L (en) 1975-01-13
AR204928A1 (es) 1976-03-19
SE416202B (sv) 1980-12-08
FR2274298B1 (es) 1978-07-21
EG11259A (en) 1977-01-31
GB1431589A (en) 1976-04-07
CA1049524A (en) 1979-02-27
LU70507A1 (es) 1974-11-28
SU559647A3 (ru) 1977-05-25
FI213274A (es) 1975-01-14
BG25792A3 (en) 1978-12-12
PL98705B1 (pl) 1978-05-31
ES428246A1 (es) 1976-07-16
PH11618A (en) 1978-04-12
NL7408942A (nl) 1975-01-15
DD112449A5 (es) 1975-04-12
SU571193A3 (ru) 1977-08-30
DK334674A (es) 1975-03-03
ATA552674A (de) 1978-04-15
PL96460B1 (pl) 1977-12-31
DE2433625A1 (de) 1975-01-30
MW2674A1 (en) 1975-05-13
AR202618A1 (es) 1975-06-24
PL98609B1 (pl) 1978-05-31
IL45006A0 (en) 1974-09-10
NO143063B (no) 1980-09-01
NO143063C (no) 1980-12-10
ES437769A1 (es) 1977-02-01
US4499101A (en) 1985-02-12

Similar Documents

Publication Publication Date Title
AR201880A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol
AR208397A1 (es) Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
MX152550A (es) Procedimiento para la preparacion de derivados de fenilnonatetraenos substituidos
AR202618A1 (es) Procedimiento para la preparacion de metiltioalquilguanidinas heterociclicas
AR204996A1 (es) Procedimiento para la preparacion de 5-metil-7-hidroxi o 7-alcoxi-isoflavonas
MX4592E (es) Procedimiento para la preparacion de 1-ariloxi-2-hidroxi-3-alquinilaminopropanos
AR206315A1 (es) Procedimiento para la preparacion de compuestos de cefalosporina
AR210725A1 (es) Procedimiento para la preparacion de derivados de dibenzoxepina
RO70474A (ro) PROCEDEU PENTRU PREPARAREA PARAXILENULёI
MX3765E (es) Procedimiento para la preparacion de derivados de piperidina
AR203188A1 (es) Procedimiento para la preparacion de derivados de tienotriazolodiacepina
AR198940A1 (es) Procedimiento para la preparacion de urea
TR17584A (tr) Herbisid triazinlerinin hazirlanmasina mahsus usul
AR206610A1 (es) Procedimiento de preparacion de 2-metoxi-5-sulfonil(sustituidos)-benzamidas-(-sustituidas
AR207022A1 (es) Procedimiento para la preparacion de poli-n-dimetiliminoalano
AR208184A1 (es) Procedimiento para la fabricacion de derivados de 2-(aminocarbonil-aza-alcanamido)-benzofenoma
AR206632A1 (es) Procedimiento para la preparacion de d-homoesteroides
AR201343A1 (es) Procedimiento para la preparacion de compuestos de quinoxalindiona sustituidos
AR208187A1 (es) Metodo para la preparacion derivados de n-carbamoil-2-feniletensulfonamida
AR203196A1 (es) Procedimiento para la preparacion de derivados de imidazol-5-carboxamidoxima
AR209281A1 (es) Procedimiento de preparacion de derivados de ciclopropilfenilpirrolidina
AR197762A1 (es) Procedimiento para la preparacion de 3-carbetoxihidrazinopiridazinas 6-sustituidas
AR209616A1 (es) Procedimiento para la preparacion de derivados de 17alpha-aciloxi-d-homo-pregn-4-eno-3,20-diona
AR211695A1 (es) Procedimiento para la preparacion de derivados de aminoscilanilidas primarias
AR202848A1 (es) Procedimiento para la preparacion de derivados de triazolobenzodiacepinas